Investigators sought to determine the safety and efficacy of novel oral anticoagulants to treat patients with chronic kidney disease, particularly with regard to cardiovascular outcomes.
Peripartum neuraxial analgesia may not be associated with an increased risk for multiple sclerosis relapse.
Individuals with long working hours (LWHs) have an increased risk for stroke, with a stronger correlation for those exposed to LWHs for 10 years or more.
International Parkinson’s and Movement Disorder Society released recommendations on clinical screening instruments and rating scales used to measure impulsive and compulsive behaviors in Parkinson disease.
The investigational therapy works by delivering a working copy of CLN1 gene using an a one-time adeno-associated virus 9 vector platform.
Investigators sought to determine the risk for Parkinson disease development in patients with hepatitis C virus who received antiviral treatment and in patients who did not receive this treatment.
Researchers compared long-term information-processing efficiency between patients with pediatric-onset MS and those with adult-onset MS in a longitudinal cohort study.
Adhansia XR (methylphenidate HCl extended-release capsules) is expected to be available as of July 15, 2019 for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older, according to Adlon Therapeutics.
There is a higher likelihood of the development of post-stroke epilepsy in patients who had longer duration of early-onset post-stroke status epilepticus.
Adults with migraine have abnormal thalamo-cortical networks and dysrhythmia along with migraine-related deficits in brain function.
Researchers analyzed patients’ perceptions of how reading physicians’ notes online influences factors associated with medication adherence.
For patients with mild-to-moderate Alzheimer disease, treatment with nilvadipine lowers systolic blood pressure and increases cerebral blood flow (CBF) in the hippocampus.
Three large drug makers have launched a legal challenge against the Trump administration’s rule requiring the prices of drugs to be included in television ads.
The Drug Enforcement Agency (DEA) has designated Sunosi (solriamfetol; Jazz Pharmaceuticals) a Schedule IV controlled substance.
Incident coronary heart disease (CHD) is associated with accelerated cognitive decline after, but not before, the event.
A study found that rotavirus infection is associated with lesions in the splenium of the corpus callosum in patients with benign convulsions with mild gastroenteritis.
Perinatal maternal depressive symptoms were consistently associated with brain development in offspring at age 10 years.
Patients with midlife type 2 diabetes have a significantly increased risk for cerebral infarction and occlusion of cerebral arteries later in life.
Facial and head injuries from electric scooter accidents have tripled during the past decade.
Findings seen among Dutch children exposed to one of four common antiepileptic drugs in utero. Researchers noted high percentages of children with clinically relevant behavior problems across all four antiepileptic drug exposure groups.